ClinicalTrials.Veeva

Menu

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Astellas logo

Astellas

Status

Completed

Conditions

Post-operative Peripheral Neuropathic Pain

Treatments

Drug: Qutenza

Study type

Observational

Funder types

Industry

Identifiers

NCT02171182
0805-MA-1001

Details and patient eligibility

About

The aim of this study is to monitor the effectiveness and used dosage of the 8% capsaicin patch in real-life clinical practice in the treatment of post-operative neuropathic pain.

Enrollment

319 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed peripheral post-operative neuropathic pain

Exclusion criteria

  • hypersensitivity to capsaicin
  • pregnancy
  • diabetes mellitus
  • treatment of face

Trial design

319 participants in 1 patient group

Qutenza patients w/ post-operative peripheral neuropathic pain
Treatment:
Drug: Qutenza

Trial contacts and locations

29

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems